Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide epitope identification for tumor-reactive CD4 T cells
Hiroya Kobayashi, Esteban Celis
Current Opinion in Immunology (2008) Vol. 20, Iss. 2, pp. 221-227
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
Yann Godet, Elizabeth Fabre, Magalie Dosset, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 10, pp. 2943-2953
Open Access | Times Cited: 92
Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer
Caroline Laheurte, Magalie Dosset, Déwi Vernerey, et al.
British Journal of Cancer (2019) Vol. 121, Iss. 5, pp. 405-416
Open Access | Times Cited: 74
Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses
Takumi Kumai, Sujin Lee, Hyun-Il Cho, et al.
Cancer Immunology Research (2016) Vol. 5, Iss. 1, pp. 72-83
Open Access | Times Cited: 69
Identification of T-cell epitopes in African swine fever virus CD2v and C-type lectin proteins
Galina Koltsova, Alexander Malogolovkin, E. R. Tulman, et al.
Journal of General Virology (2019) Vol. 100, Iss. 2, pp. 259-265
Open Access | Times Cited: 58
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
Hussein Sultan, Juan Wu, Valentyna I. Fesenkova, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001224-e001224
Open Access | Times Cited: 51
Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Magalie Dosset, Yann Godet, Charline Vauchy, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 22, pp. 6284-6295
Open Access | Times Cited: 64
EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
Takumi Kumai, Yoshinari Matsuda, Kensuke Oikawa, et al.
British Journal of Cancer (2013) Vol. 109, Iss. 8, pp. 2155-2166
Open Access | Times Cited: 63
First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
Norihiko Takahashi, Takayuki Ohkuri, Shigenori Homma, et al.
Cancer Science (2012) Vol. 103, Iss. 1, pp. 150-153
Open Access | Times Cited: 60
Cancer immunotherapy: moving forward with peptide T cell vaccines
Takumi Kumai, Aaron E. Fan, Yasuaki Harabuchi, et al.
Current Opinion in Immunology (2017) Vol. 47, pp. 57-63
Open Access | Times Cited: 57
Identification of 4 new HLA-DR–restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity
Anita N. Stumpf, Edith D. van der Meijden, Cornelis A.M. van Bergen, et al.
Blood (2009) Vol. 114, Iss. 17, pp. 3684-3692
Closed Access | Times Cited: 68
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
Jeanne Galaine, Christophe Borg, Yann Godet, et al.
Vaccines (2015) Vol. 3, Iss. 3, pp. 490-502
Open Access | Times Cited: 43
Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy
Mohsen Sheykhhasan, Amirhossein Ahmadieh-Yazdi, Reza Heidari, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117858-117858
Closed Access
Recent update on multi-epitope vaccine development for treating breast cancer
Z. Nafiah, A. Atha, Anggraini Ihza Rizkita, et al.
Vacunas (2025), pp. 500390-500390
Closed Access
Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: A biotech's challenge
Sandra Iurescia, Daniela Piergili Fioretti, Vito Michele Fazio, et al.
Biotechnology Advances (2011) Vol. 30, Iss. 1, pp. 372-383
Closed Access | Times Cited: 43
Developing an Effective Breast Cancer Vaccine
Hatem Soliman
Cancer Control (2010) Vol. 17, Iss. 3, pp. 183-190
Open Access | Times Cited: 43
Combination immunotherapy with radiation and CpG‐based tumor vaccination for the eradication of radio‐ and immuno‐resistant lung carcinoma cells
Kenji Chamoto, Tsuguhide Takeshima, Daiko Wakita, et al.
Cancer Science (2009) Vol. 100, Iss. 5, pp. 934-939
Open Access | Times Cited: 41
A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses
Mohan Karkada, Genevieve Weir, Tara Quinton, et al.
Journal of Immunotherapy (2010) Vol. 33, Iss. 3, pp. 250-261
Closed Access | Times Cited: 33
Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
Satoshi Hayashi, Takumi Kumai, Yoshiya Matsuda, et al.
Journal of Translational Medicine (2011) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
Junya Ohtake, Takayuki Ohkuri, Yuji Togashi, et al.
Immunology Letters (2014) Vol. 161, Iss. 1, pp. 20-30
Closed Access | Times Cited: 28
Antitumor effect of new HER2 peptide vaccination based on B cell epitope.
Hirohito Miyako, Yoshie Kametani, Ikumi Katano, et al.
PubMed (2011) Vol. 31, Iss. 10, pp. 3361-8
Closed Access | Times Cited: 28
Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration
Mohan Karkada, Tara Quinton, Rachelle Blackman, et al.
ISRN Oncology (2013) Vol. 2013, pp. 1-13
Open Access | Times Cited: 23
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells
Jeanne Galaine, Guillaume Kellermann, Yves Claude Guillaume, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 5, pp. 1597-1608
Open Access | Times Cited: 19
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine
Olivier Adotévi, Magalie Dosset, Jeanne Galaine, et al.
Human Vaccines & Immunotherapeutics (2013) Vol. 9, Iss. 5, pp. 1073-1077
Open Access | Times Cited: 19
Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
Magalie Dosset, Charline Vauchy, Laurent Beziaud, et al.
OncoImmunology (2013) Vol. 2, Iss. 3, pp. e23430-e23430
Open Access | Times Cited: 17
Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells
Takayuki Ohkuri, Daiko Wakita, Kenji Chamoto, et al.
British Journal of Cancer (2009) Vol. 100, Iss. 7, pp. 1135-1143
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top